#Julphar

UAE’s Julphar announces 90% increase in revenues for Q2 2020

The company has announced a net loss of Dhs25.6m for Q2 2020

Ras Al Khaimah pharma company Julphar launches Dhs500m rights issue

The new capital is also expected to help it expand operations in key markets in the region

UAE pharma Julphar resumes exports to Saudi after suspension

The kingdom banned Julphar’s products in September 2018 for failing to meet regional standards

Julphar Signs Insulin Deal With US-Based Firm

Under the deal, EMD Millipore will sell recombinant human insulin manufactured by UAE-based pharmaceutical firm Julphar.

Julphar’s H1 Revenue Up 13.5%

The pharmaceutical company has seen a profit rise of 5.6 per cent for the first half of last year, with operating profit also up.